Compare VTAK & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTAK | SOBR |
|---|---|---|
| Founded | 2002 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 3.3M |
| IPO Year | 2018 | 2008 |
| Metric | VTAK | SOBR |
|---|---|---|
| Price | $1.38 | $0.73 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 64.8K | ★ 151.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.53 | 72.19 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $442,000.00 | $212,736.00 |
| Revenue This Year | $822.86 | N/A |
| Revenue Next Year | $168.42 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3057.14 | 35.25 |
| 52 Week Low | $0.15 | $0.46 |
| 52 Week High | $4.31 | $7.70 |
| Indicator | VTAK | SOBR |
|---|---|---|
| Relative Strength Index (RSI) | 36.38 | 33.63 |
| Support Level | $1.14 | $0.66 |
| Resistance Level | $2.05 | $2.19 |
| Average True Range (ATR) | 0.12 | 0.07 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 16.67 | 35.21 |
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.